- Home
- KLTR vs CDXS Comparison
KLTR vs CDXS Comparison
Compare KLTR & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTR
- CDXS
- Stock Information
- Founded
- KLTR 2006
- CDXS 2002
- Country
- KLTR United States
- CDXS United States
- Employees
- KLTR N/A
- CDXS N/A
- Industry
- KLTR EDP Services
- CDXS Major Chemicals
- Sector
- KLTR Technology
- CDXS Industrials
- Exchange
- KLTR Nasdaq
- CDXS Nasdaq
- Market Cap
- KLTR 302.6M
- CDXS 254.3M
- IPO Year
- KLTR 2021
- CDXS 2010
- Fundamental
- Price
- KLTR $1.68
- CDXS $2.43
- Analyst Decision
- KLTR Buy
- CDXS Buy
- Analyst Count
- KLTR 3
- CDXS 2
- Target Price
- KLTR $2.83
- CDXS $11.00
- AVG Volume (30 Days)
- KLTR 264.1K
- CDXS 1.0M
- Earning Date
- KLTR 11-05-2025
- CDXS 10-30-2025
- Dividend Yield
- KLTR N/A
- CDXS N/A
- EPS Growth
- KLTR N/A
- CDXS N/A
- EPS
- KLTR N/A
- CDXS N/A
- Revenue
- KLTR $181,350,000.00
- CDXS $57,164,000.00
- Revenue This Year
- KLTR $3.43
- CDXS $12.88
- Revenue Next Year
- KLTR $2.96
- CDXS $21.64
- P/E Ratio
- KLTR N/A
- CDXS N/A
- Revenue Growth
- KLTR 2.56
- CDXS N/A
- 52 Week Low
- KLTR $1.23
- CDXS $1.90
- 52 Week High
- KLTR $2.82
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- KLTR 55.44
- CDXS 38.20
- Support Level
- KLTR $1.67
- CDXS $2.38
- Resistance Level
- KLTR $1.74
- CDXS $2.54
- Average True Range (ATR)
- KLTR 0.09
- CDXS 0.11
- MACD
- KLTR 0.03
- CDXS -0.00
- Stochastic Oscillator
- KLTR 75.61
- CDXS 28.00
About KLTR Kaltura Inc.
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.